The structural basis of the recognition of phenylalanine and pterin cofactors by phenylalanine hydroxylase: Implications for the catalytic mechanism

Journal of Molecular Biology

Volumn 294, Issue 3, 1999, Pages 807-823

  Teigen, Knut ^a   Frøystein, Nils Åge ^a   Martínez, Aurora ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

1H NMR spectroscopy; Docking; Non heme iron; Phenylalanine hydroxylase; Phenylketonuria

Indexed keywords

IRON; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; PTERIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ESCHERICHIA COLI; HUMAN; HYDROGEN BOND; HYDROXYLATION; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL;

EID: 0033521234     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3288     Document Type: Article

References (62)

1. Aberg A., Yaremchuk A., Tukalo M., Rasmussen B., Cusack S. Crystal structure analysis of the activation of histidine by Thermus thermophilus histidyl-tRNA synthetase. Biochemistry. 36:1997;3084-3094.
2. Al-Karaghouli A. R., Koetzle T. F. Neutron difraction study of L-phenylalanine hydrochloride. Acta Crystallog. sect B. 31:1975;2461-2465.
3. Auerbach G., Herrmann A., Gutlich M., Fischer M., Jacob U., Bacher A., Huber R. The 1.25 Å crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters. EMBO J. 16:1997;7219-7230.
4. Bailey S. W., Ayling J. E. 6,6-Dimethylpterins: stable quinoid dihydropterin substrate for dihydropteridine reductase and tetrahydropterin cofactor for phenylalanine hydroxylase. Biochemistry. 22:1983;1790-1798.
5. Banci L., Bertini I., Luchinat C. Nuclear relaxation in paramagnetic systems. Nuclear and Electron Relaxation. The Magnetic Nucleus-Unpaired Electron Coupling in Solution. 1991;VCH Verlagsgesellschaft mbH, Weinheim. p. 91-122.
6. Bieri J. H. The crystal structure of 6-methyl-7, 8-dihydropterine-monohydrochloride-monohydrate. Helv. Chim. Acta. 60:1977;2303-2308.
7. Bjørgo E., Knappskog P. M., Martínez A., Stevens R. C., Flatmark T. Partial characterization and three-dimensional-structural localization of eight mutations in exon 7 of the human phenylalanine hydroxylase gene associated with phenylketonuria. Eur. J. Biochem. 257:1998;1-10.
8. Bublitz C. Two mechanisms for the inhibition in vitro of phenylalanine hydroxylase by catecholamines. Biochem. Pharmacol. 20:1971;2543-2553.
9. Campbell A. P., Sykes B. D. The two-dimensional transferred nuclear Overhauser effect: theory and practice. Annu. Rev. Biophys. Biomol. Struct. 22:1993;99-122.
10. Clore G. M., Gronenborn A. M. Theory and applications of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J. Magn. Reson. 48:1982;402-417.
11. Crane B. R., Arvai A. S., Ghosh D. K., Wu C., Getzoff E. D., Stuehr D. J., Tainer J. A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 279:1998;2121-2126.
12. Daubner S. C., Fitzpatrick P. F. Site-directed mutants of charged residues in the active site of tyrosine hydroxylase. Biochemistry. 38:1999;4448-4454.
13. Daubner S. C., Hillas P. J., Fitzpatrick P. F. Characterization of chimeric pterin-dependent hydroxylases: contributions of the regulatory domains of tyrosine and phenylalanine hydroxylase to substrate specificity. Biochemistry. 36:1997;11574-11582.
14. Davis M. D., Kaufman S. Evidence for the formation of the 4a-carbinolamine during the tyrosine- dependent oxidation of tetrahydrobiopterin by rat liver phenylalanine hydroxylase. J. Biol. Chem. 264:1989;8585-8596.
15. Dickson P. W., Jennings I. G., Cotton R. G. Delineation of the catalytic core of phenylalanine hydroxylase and identification of glutamate 286 as a critical residue for pterin function. J. Biol. Chem. 269:1994;20369-20375.
16. Dix T. A., Benkovic S. J. Mechanism of oxygen activation by pteridine-dependent moooxygenases. Acc. Chem. Res. 21:1988;101-107.
17. Erlandsen H., Fusetti F., Martínez A., Hough E., Flatmark T., Stevens R. C. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nature Struct. Biol. 4:1997;995-1000.
18. Erlandsen H., Flatmark T., Stevens R. C., Hough E. Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 Å resolution. Biochemistry. 37:1998;15638-15646.
19. Etter M. C., Adsmond D. A. The use of cocrystallization as a method of stidying hydrogen bond preferences of 2-aminopyrimidine. J. Chem. Soc. Chem. Commun. 8:1990;589-591.
20. Fitzpatrick P. F. Steady-state kinetic mechanism of rat tyrosine hydroxylase. Biochemistry. 30:1991;3658-3662.
21. Flatmark T., Stevens R. C. Structural insights into the aromatic amino acid hydroxylases and their disease-related mutant forms. Chem. Rev. 99:1999;2137-2160.
22. Francisco W. A., Tian G. C., Fitzpatrick P. F., Klinman J. P. Oxygen-18 kinetic isotope effect studies of the tyrosine hydroxylase reaction: Evidence of rate limiting oxygen activation. J. Am. Chem. Soc. 120:1998;4057-4062.
23. Fusetti F., Erlandsen H., Flatmark T., Stevens R. C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J. Biol. Chem. 273:1998;16962-16967.
24. Goodwill K. E., Sabatier C., Marks C., Raag R., Fitzpatrick P. F., Stevens R. C. Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases. Nature Struct. Biol. 4:1997;578-585.
25. Goodwill K. E., Sabatier C., Stevens R. C. Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 Å resolution: self-hydroxylation of Phe300 and the pterin-binding site. Biochemistry. 37:1998;13437-13445.
26. Havel T. F. An evaluation of computational strategies for use in the determination of protein-structure from distance constraints obtained by nuclear-magnetic-resonance. Prog. Biophys. Mol. Biol. 56:1991;43-78.
27. Haavik J., Flatmark T. Isolation and characterization of tetrahydropterin oxidation products generated in the tyrosine 3-monooxygenase (tyrosine hydroxylase) reaction. Eur. J. Biochem. 168:1987;21-26.
28. Haavik J., Doskeland A. P., Flatmark T. Stereoselective effects in the interactions of pterin cofactors with rat-liver phenylalanine 4-monooxygenase. Eur. J. Biochem. 160:1986;1-8.
29. Kappock T. J., Caradonna J. P. Pterin-dependent amino acid hydroxylases. Chem. Rev. 96:1996;2659-2756.
30. Katoh S., Sueoka T., Kurihara T. Theoretical stereostructure of the neutral form of natural tetrahydrobiopterin. Pteridines. 4:1993;27-31.
31. Kaufman S. The phenylalanine hydroxylating system. Advan. Enzymol. Relat. Areas Mol. Biol. 67:1993;77-264.
32. Kemsley J. N., Mitic N., Zaleski K. L., Caradonna J. P., Solomon I. Circular dichroism and magnetic circular dichroism spectroscopy of the catalytically competent ferrous active site of phenylalanine hydroxylase and its interaction with pterin cofactor. J. Am. Chem. Soc. 121:1999;1528-1536.
33. Knappskog P. M., Haavik J. Tryptophan fluorescence of human phenylalanine hydroxylase produced in Escherichia coli. Biochemistry. 34:1995;11790-11799.
34. Knappskog P. M., Eiken H. G., Martínez A., Flatmark T., Apold J. The PKU mutation S349P causes complete loss of catalytic activity in the recombinant phenylalanine hydroxylase enzyme. Hum. Genet. 95:1995;171-173.
35. Knappskog P. M., Flatmark T., Aarden J. M., Haavik J., Martínez A. Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme. Eur. J. Biochem. 242:1996;813-821.
36. Kobe B., Jennings I. G., House C. M., Michell B. J., Goodwill K. E., Santarsiero B. D., Stevens R. C., Cotton R. G., Kemp B. E. Structural basis of autoregulation of phenylalanine hydroxylase. Nature Struct. Biol. 6:1999;442-448.
37. Kowalewski J., Nordenskiold L., Benetis N., Westlund P.-O. Theory of nuclear spin relaxation in paramagnetic systems in solution. Prog. NMR Spectrosc. 17:1985;141-185.
38. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
39. Lange S., Que L. J. Oxygen activating nonheme iron enzymes. Curr. Opin. Chem. Biol. 2:1998;159-172.
40. Martínez A., Haavik J., Flatmark T. Cooperative homotropic interaction of L-noradrenaline with the catalytic site of phenylalanine 4-monooxygenase. Eur. J. Biochem. 193:1990;211-219.
41. 1H-NMR spectroscopic studies on the paramagnetic iron at the active site of phenylalanine hydroxylase and its interaction with substrates and inhibitors. Eur. J. Biochem. 198:1991;675-682.
42. Martínez A., Abeygunawardana C., Haavik J., Flatmark T., Mildvan A. S. Conformation and interaction of phenylalanine with the divalent cation at the active site of human recombinant tyrosine hydroxylase as determined by proton NMR. Biochemistry. 32:1993a;6381-6390.
43. 1H-NMR paramagnetic relaxation. Changes in water accessibility to the iron at the active site upon substrate binding. Eur. J. Biochem. 211:1993b;259-266.
44. Martínez A., Vageli O., Pfleiderer W., Flatmark T. Proton NMR studies on the conformation of the pterin cofactor bound at the active site of recombinant human tyrosine hydroxylase. Pteridines. 9:1998;44-52.
45. Matsuura S., Sugimoto T., Murata S., Sugawara Y., Iwasaki H. Stereochemistry of biopterin cofactor and facile methods for the determination of the stereochemistry of a biologically active 5,6,7,8- tetrahydropterin. J. Biochem. (Tokyo). 98:1985;1341-1348.
46. + and biopterin. Biochemistry. 31:1992;7264-7273.
47. Meng E. C., Shoichet B. K., Kuntz I. D. Automated docking with grid-based energy evaluation. J. Comput. Chem. 13:1992;505-524.
48. Merritt E. A., Murphy M. E. P. Raster3D version-2.0 - a program for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873.
49. Meyer-Klaucke W., Winkler H., Schunemann V., Trautwein A. X., Nolting H. F., Haavik J. Mössbauer, electron-paramagnetic-resonance and X-ray-absorption fine- structure studies of the iron environment in recombinant human tyrosine hydroxylase. Eur. J. Biochem. 241:1996;432-439.
50. Mildvan A. S., Granot J., Smith G. M., Liebman M. N. Nuclear magnetic relaxation rates. Advan. Inorg. Biochem. 2:1980;211-236.
51. Nar H., Huber R., Auerbach G., Fischer M., Hosl C., Ritz H., Bracher A., Meining W., Eberhardt S., Bacher A. Active site topology and reaction mechanism of GTP cyclohydrolase I. Proc. Natl Acad. Sci. USA. 92:1995;12120-12125.
52. Odani A., Masuda H., Inukai K., Yamauchi O. Pteridine-containing ternary and quaternary complexes as models for metalloenzyme-pterin cofactor-substrate association - Structure of ternary copper(II)-2,2′-bipyridine lumazine complex and successful equilibrium study of a quaternary copper(II) system. J. Am. Chem. Soc. 114:1992;6294-6300.
53. Oh B. H., Kang C. H., De Bondt H., Kim S. H., Nikaido K., Joshi A. K., Ames G. F. The bacterial periplasmic histidine-binding protein. structure/function analysis of the ligand-binding site and comparison with related proteins. J. Biol. Chem. 269:1994;4135-4143.
54. 1H NMR paramagnetic relaxation. Effect of L-Phe and comparison with the rat enzyme. J. Biol. Chem. 274:1999;6280-6284.
55. Piotto M., Saudek V., Sklenar V. Gradient- tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 2:1992;661-665.
56. Ploom T., Hauβmann C., Hof P., Steinbacher S., Bacher A., Richardson J., Huber R. Crystal structure of 7,8-dihydroneopterin triphosphate epimerase. Structure. 7:1999;509-516.
57. Raman C. S., Li H., Martasek P., Kral V., Masters B. S., Poulos T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 95:1998;939-950.
58. Schünemann V., Meier C., Meyer-Klaucke W., Winkler H., Trautwein A. X., Knappskog P. M., Toska K., Haavik J. J. Bioinorg. Chem. 4:1999;223-231.
59. Shiman R., Xia T., Hill M. A., Gray D. W. Regulation of rat liver phenylalanine hydroxylase. II. Substrate binding and the role of activation in the control of enzymatic activity. J. Biol. Chem. 269:1994;24647-24656.
60. Sklenár V., Piotto M., Leppik R., Saudek V. Gradient-tailored water suppression for H-1-N-15 HSQC experiments optimized to retain full sensitivity. J. Magn. Reson. 102:1993;241-245.
61. Svensson E., Eisensmith R. C., Dworniczak B., von Dobeln U., Hagenfeldt L., Horst J., Woo S. L. Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum. Mutat. 1:1992;129-137.
62. Williams T. C., Storm C. B. Tetrahydrobiopterin analogues: solution conformations of 6-methyltetrahydropterin, 7-methyltetrahydropterin, and cis- and trans- 6,7-dimethyltetrahydropterins as determined by proton nuclear magnetic resonance. Biochemistry. 24:1985;458-466.